North American Injectables Drug Delivery devices Market Research Report
- Report Code: IN 1001
- Publish Date: Upcoming
The North American Injectable Drug Delivery Devices Market, mainly driven by a growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer was valued at $4.6 billion in 2013 and expected to be $7.2 billion by 2018, growing at a CAGR of 9.2%.
The report “North American Injectable Drug Delivery Devices Market forecast, 2012-2018 “analyzes the market of devices by segments such as Conventional injectable devices, Self injection devices, other injectable devices.
North America is expected to dominate the overall Injectable Drug Delivery Devices Market in terms of share throughout the forecast period. The presence of growing per capita healthcare expenditures, high patient awareness levels and well defined and supportive reimbursement structure are some of the factors attributing to the aforementioned conclusion.
The report also provides an extensive competitive landscaping of companies operating in Injectable Drug Delivery Devices Market. The main companies operating in Injectable Drug Delivery Devices market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of Injectable Drug Delivery Devices products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of diabetes, multiple sclerosis, rheumatoid arthritis, cancer.
- Country specific Patient pool of diabetes, multiple sclerosis, rheumatoid arthritis, cancer
- Disease progression (Pattern analysis)
Pharmacists Forum
- Fast turn-around analysis of Pharmacists response to market events and trends
- Pharmacists opinion about Injectable Drug Delivery devices products from different companies
- Pharmacists qualitative inputs on epidemiology data
- Pattern analysis of usage of drugs by physicians
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Competitive Intelligence
- The company share analysis of Injectable Drug Delivery Systems for the top players of the market in the North America.
- The crucial developments and strategies of companies inculcating in their portfolio for Injectable Drug Delivery Systems.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Drug Delivery Devices Market The North American Drug Delivery Devices Market was valued at $16 billion in 2013 and expected to be $110 billion by 2018, growing at a CAGR of 8.9%. The report “North American Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in Drug Delivery Devices market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.). |
Upcoming |
|
|
European Drug Delivery Devices Market The European Drug Delivery Devices Market was valued at $45 billion in 2013 and expected to be $63 billion by 2018, growing at a CAGR of 8.3%. The report “European Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in Drug Delivery Devices market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.). |
Upcoming |
|
|
Asian Drug Delivery Devices Market The Asian Drug Delivery Devices Market was valued at $28 billion in 2013 and expected to be $50 billion by 2018, growing at a CAGR of 12.6%. The report “Asian Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in this market and extensively covered in this report are 3M Company, Alkermes, Baxter International, Inc., Becton, Dickinson & Co., The Dow Chemical Company, Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC,. |
Upcoming |
